Guardant Health
GH
#1160
Rank
โ‚ฌ17.59 B
Marketcap
132,68ย โ‚ฌ
Share price
-1.60%
Change (1 day)
200.53%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ1.83 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are โ‚ฌ1.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ1.79 B15.17%
2024-12-31โ‚ฌ1.56 B6.07%
2023-12-31โ‚ฌ1.47 B1.91%
2022-12-31โ‚ฌ1.44 B4.92%
2021-12-31โ‚ฌ1.37 B84.87%
2020-12-31โ‚ฌ0.74 B628.49%
2019-12-31โ‚ฌ0.10 B87.3%
2018-12-31โ‚ฌ54.59 M90.79%
2017-12-31โ‚ฌ28.61 M-18.37%
2016-12-31โ‚ฌ35.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Neogen
NEOG
โ‚ฌ1.10 B-40.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚ฌ0.73 B-59.91%๐Ÿ‡บ๐Ÿ‡ธ USA